This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by El-Sheikh, A. Articles by Edgington, T. S. Search for Related Content PubMed PubMed Citation Articles by El-Sheikh, A. Articles by Edgington, T. S.

A Novel Vascular Endothelial Growth Factor Heparin-binding Domain Substructure Binds to Glycosaminoglycans in Vivo and Localizes to Tumor Microvascular Endothelium¹

Department of Immunology, The Scripps Research Institute, La Jolla, California 92037

Vascular endothelial growth factor has an exon 7-encoded heparin-binding domain. To explore the expression of complementary ligands on endothelial surfaces in vivo and to assess potential for localization within the vascular tree, we introduced a truncated version of this domain (HBDt) into a modified M13 phage. Despite the small size and trace-level expression, this HBDt endowed the phage with affinity for heparin to which it bound in vitro. It also preferentially and selectively localized the phage in vivo to vascular endothelial surfaces, especially of tumors. Competition assays demonstrated that accumulation and localization of this phage was attributable to expression of the HBDt on the phage surface and sequence comparison suggests its novelty. We propose to use this novel HBDt structure to explore the expression of the ligand glycosaminoglycans within the vascular tree. This structure may facilitate directed delivery of therapeutic molecules.

This article has been cited by other articles:

				T. A.H. Jarvinen and E. Ruoslahti Molecular Changes in the Vasculature of Injured Tissues Am. J. Pathol., August 1, 2007; 171(2): 702 - 711. [Abstract] [Full Text] [PDF]

				R. Rajgopal, M. Butcher, J. I. Weitz, and S. G. Shaughnessy Heparin Synergistically Enhances Interleukin-11 Signaling through Up-regulation of the MAPK Pathway J. Biol. Chem., July 28, 2006; 281(30): 20780 - 20787. [Abstract] [Full Text] [PDF]

				A. El-Sheikh, P. Borgstrom, G. Bhattacharjee, M. Belting, and T. S. Edgington A Selective Tumor Microvasculature Thrombogen that Targets a Novel Receptor Complex in the Tumor Angiogenic Microenvironment Cancer Res., December 1, 2005; 65(23): 11109 - 11117. [Abstract] [Full Text] [PDF]

				C. Liu, C. Dickinson, J. Shobe, F. Donate, W. Ruf, and T. Edgington A hybrid fibronectin motif protein as an integrin targeting selective tumor vascular thrombogen Mol. Cancer Ther., July 1, 2004; 3(7): 793 - 801. [Abstract] [Full Text] [PDF]

				S. Christian, J. Pilch, M. E. Akerman, K. Porkka, P. Laakkonen, and E. Ruoslahti Nucleolin expressed at the cell surface is a marker of endothelial cells in angiogenic blood vessels J. Cell Biol., November 24, 2003; 163(4): 871 - 878. [Abstract] [Full Text] [PDF]